Evidence map›Paper›PMID 33872783›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021

First case of postmortem study in a patient vaccinated against SARS-CoV-2.

Torsten Hansen, Ulf Titze, Nidhi Su Ann Kulamadayil-Heidenreich, Sabine Glombitza, Johannes Josef Tebbe, Christoph Röcken, Birte Schulz, Michael Weise, Ludwig Wilkens

Open access · goldAbstract readCase Reports
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. High viral loads: what drives fatal cases of COVID-19 in vaccinees? - an autopsy study.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Torsten HansenInstitute of Pathology, University Hospital OWL of the University of Bielefeld, Campus Lippe, Detmold, Germany. Electronic address: Torsten.Hansen@klinikum-lippe.de.
Ulf TitzeInstitute of Pathology, University Hospital OWL of the University of Bielefeld, Campus Lippe, Detmold, Germany.
Nidhi Su Ann Kulamadayil-HeidenreichDepartment of Internal Medicine, Gastroenterology and Infectious Medicine, University Hospital OWL of the University of Bielefeld, Campus Lippe, Detmold, Germany.
Sabine GlombitzaInstitute of Pathology, KRH Hospital Nordstadt, Hannover, Germany.
Johannes Josef TebbeDepartment of Internal Medicine, Gastroenterology and Infectious Medicine, University Hospital OWL of the University of Bielefeld, Campus Lippe, Detmold, Germany.
Christoph RöckenInstitute of Pathology of the University of Schleswig-Holstein, Campus Kiel, Germany.
Birte SchulzInstitute of Pathology, University Hospital OWL of the University of Bielefeld, Campus Lippe, Detmold, Germany.
Michael WeiseDepartment of Internal Medicine, Gastroenterology and Infectious Medicine, University Hospital OWL of the University of Bielefeld, Campus Lippe, Detmold, Germany.
Ludwig WilkensInstitute of Pathology, KRH Hospital Nordstadt, Hannover, Germany.
KRH Klinikum Nordstadt · DEChristian-Albrechts-Universität zu Kiel · DEKlinikum Lippe · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A previously symptomless 86-year-old man received the first dose of the BNT162b2 mRNA COVID-19 vaccine. He died 4 weeks later from acute renal and respiratory failure. Although he did not present with any COVID-19-specific symptoms, he tested positive for SARS-CoV-2 before he died. Spike protein (S1) antigen-binding showed significant levels for immunoglobulin (Ig) G, while nucleocapsid IgG/IgM was not elicited. Acute bronchopneumonia and tubular failure were assigned as the cause of death at autopsy; however, we did not observe any characteristic morphological features of COVID-19. Postmortem molecular mapping by real-time polymerase chain reaction revealed relevant SARS-CoV-2 cycle threshold values in all organs examined (oropharynx, olfactory mucosa, trachea, lungs, heart, kidney and cerebrum) except for the liver and olfactory bulb. These results might suggest that the first vaccination induces immunogenicity but not sterile immunity.

Indexed as

VaccinationAged, 80 and overAntibodies, ViralAutopsyBNT162 VaccineCOVID-19COVID-19 VaccinesHumansMaleSARS-CoV-2Antibodies, ViralBNT162 VaccineCOVID-19 VaccinesAutopsyHistologyRT-PCRSARS-CoV-2Vaccine

Identifiers

PMID33872783
PMCPMC8051011
OpenAlexW3154275593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.